About Sculptra® by Galderma
Sculptra® is an injectable biostimulator developed by Galderma, formulated with poly-L-lactic acid (PLLA). Unlike traditional dermal fillers that add volume directly, Sculptra® works gradually and biologically, stimulating the skin’s own natural collagen production to restore volume, improve skin firmness, and smooth out deep facial wrinkles and folds.
Sculptra®
Sculptra® is composed of biocompatible and biodegradable PLLA microparticles, a material that has been used safely for decades in medical applications such as dissolvable sutures. Once injected into the deep dermis, Sculptra® triggers fibroblast activity, resulting in progressive collagen regeneration over several weeks to months.
Sculptra® is ideal for the correction of shallow to deep nasolabial folds, marionette lines, and chin wrinkles. It’s also increasingly used in non-surgical facial volumization and body contouring procedures, including buttock enhancement and skin tightening in off-face areas.
Results from Sculptra® treatments typically develop over 1–3 months and can last up to 2 years or more, making it a favorite among practitioners seeking a natural-looking and long-lasting approach to facial rejuvenation.
Sculptra® is CE-marked and FDA-approved, with a strong track record of safety and efficacy in aesthetic medicine.
About Galderma
Galderma is a global leader in dermatology, dedicated to advancing skin health through science and innovation. Founded in 1981 and headquartered in Switzerland, Galderma specializes in medical and aesthetic dermatology, offering a comprehensive portfolio of trusted brands that address a wide range of skin conditions and aesthetic needs. The company partners with healthcare professionals worldwide to provide science-backed, high-performance solutions that support both skin health and self-confidence.